General Information of the Compound
Compound ID
CP0014361
Compound Name
8-[5-(difluoromethyl)pyridin-3-yl]-4-methyl-1-(oxan-4-yl)-[1,2,4]triazolo[4,3-a]quinoxaline
    Show/Hide
Formula
C21H19F2N5O
Molecular Weight
395.413
Canonical SMILES
Cc1nc2ccc(cc2n2c(nnc12)C1CCOCC1)-c1cncc(c1)C(F)F
    Show/Hide
InChI
InChI=1S/C21H19F2N5O/c1-12-20-26-27-21(13-4-6-29-7-5-13)28(20)18-9-14(2-3-17(18)25-12)15-8-16(19(22)23)11-24-10-15/h2-3,8-11,13,19H,4-7H2,1H3
    Show/Hide
InChIKey
MGWKNFSOFRTXCS-UHFFFAOYSA-N
Physicochemical Property
logP
4.47952
Rotatable Bonds
3
Heavy Atom Count
29
Polar Areas
65.2
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4847559
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01902, Serine-protein kinase ATM
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000154 HEK293-EBNA1-6E Homo sapiens (Human)  1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS